Prostate Cancer - Results from #2040

Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer. October 10, 2023

Impact of persistent PSA after salvage radical prostatectomy: a multicenter study. October 10, 2023

COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study. October 10, 2023

TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment. October 10, 2023

ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy. October 10, 2023

Deep Learning-Based T2-weighted MR Image Quality Assessment and Its Impact on Prostate Cancer Detection Rates. October 10, 2023

A Canadian center's experience on whole-gland salvage therapy for radio-recurrent prostate cancer with various modalities. October 9, 2023

Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery. October 9, 2023

Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer. October 9, 2023

Statins may increase the risk of being diagnosed with prostate cancer. October 9, 2023

Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy? October 9, 2023

Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer. October 6, 2023

Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer. October 6, 2023

Prognostic factors for mental wellbeing in prostate cancer: A systematic review and meta-analysis. October 6, 2023

Testosterone as a Biomarker for Quality of Life (QOL) Following Androgen Deprivation Therapy (ADT) and Stereotactic Body Radiotherapy (SBRT). October 6, 2023

An Actionable Expert-System Algorithm to Support Nurse-Led Cancer Survivorship Care: Algorithm Development Study. October 6, 2023

Association of PSA kinetics after testosterone recovery with subsequent recurrence: secondary analysis of a phase III randomized controlled trial. October 6, 2023

Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update From the FASTR/FASTR-2 Trials. October 6, 2023

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial. October 6, 2023

Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors. October 5, 2023

Page 103 of 1439